Evidence map›Paper›PMID 36776388›Full record

ArticleFrontiers in immunology2022

DSS-induced colitis activates the kynurenine pathway in serum and brain by affecting IDO-1 and gut microbiota.

Li-Ping Zhao, Jian Wu, Wei Quan, Yu Zhou, Hui Hong, Gu-Yu Niu, Ting Li, Shu-Bing Huang, Chen-Meng Qiao, Wei-Jiang Zhao and 2 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in immunology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 35 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
35citing papers in PubMed, 1 pooled it
3.2field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

35 citing papers in PubMed, 1 synthesis or guideline pooled it, 33 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Review
  6. International journal of molecular sciences · 2026
    Article
  7. Gut microbiota: contributing to high CVD prevalence in people living with schizophrenia?European archives of psychiatry and clinical neuroscience · 2026
    Review
  8. Article
  9. Jabuticaba (Nutrients · 2026
    Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Review
  15. Review
  16. Article
  17. Review
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 1 institution in 1 country.

Li-Ping ZhaoNeurodegeneration and Neuroinjury Laboratory, Wuxi School of Medicine, Jiangnan University, Wuxi, Jiangsu, China.
Jian WuNeurodegeneration and Neuroinjury Laboratory, Wuxi School of Medicine, Jiangnan University, Wuxi, Jiangsu, China.
Wei QuanNeurodegeneration and Neuroinjury Laboratory, Wuxi School of Medicine, Jiangnan University, Wuxi, Jiangsu, China.
Yu ZhouNeurodegeneration and Neuroinjury Laboratory, Wuxi School of Medicine, Jiangnan University, Wuxi, Jiangsu, China.
Hui HongNeurodegeneration and Neuroinjury Laboratory, Wuxi School of Medicine, Jiangnan University, Wuxi, Jiangsu, China.
Gu-Yu NiuNeurodegeneration and Neuroinjury Laboratory, Wuxi School of Medicine, Jiangnan University, Wuxi, Jiangsu, China.
Ting LiNeurodegeneration and Neuroinjury Laboratory, Wuxi School of Medicine, Jiangnan University, Wuxi, Jiangsu, China.
Shu-Bing HuangNeurodegeneration and Neuroinjury Laboratory, Wuxi School of Medicine, Jiangnan University, Wuxi, Jiangsu, China.
Chen-Meng QiaoNeurodegeneration and Neuroinjury Laboratory, Wuxi School of Medicine, Jiangnan University, Wuxi, Jiangsu, China.
Wei-Jiang ZhaoNeurodegeneration and Neuroinjury Laboratory, Wuxi School of Medicine, Jiangnan University, Wuxi, Jiangsu, China.
Chun CuiNeurodegeneration and Neuroinjury Laboratory, Wuxi School of Medicine, Jiangnan University, Wuxi, Jiangsu, China.
Yan-Qin ShenNeurodegeneration and Neuroinjury Laboratory, Wuxi School of Medicine, Jiangnan University, Wuxi, Jiangsu, China.
Jiangnan University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Accumulative studies suggest that inflammatory bowel disease (IBD) may cause multiple central nervous system (CNS) pathologies. Studies have found that indoleamine-2,3-dioxygenase (IDO, rate-limiting enzyme of the kynurenine (Kyn) pathway) deficient mice were protected from endotoxin induced cognitive impairment, and Kyn administration induced cognitive memory deficits in both control and IDO-deficient mice. However, there is no investigation of the brain Kyn pathway in IBD, thus we investigated whether dextran sulfate sodium (DSS)-induced colitis could cause dysregulation of Kyn pathway in brain, and also in serum. C57BL/6J mice were given drinking water with 2% DSS for 10 consecutive days to induce colitis. In serum, we found significant increase in Kyn and kynurenic acid (Kyna) level, which was regulated by IDO-1 and KAT2 (rate-limiting enzymes of Trp-Kyn-Kyna pathway). Similarly, by analyzing GEO datasets, higher IDO-1 levels in peripheral blood monocytes and colon of UC patients was found. Furthermore, the Kyn pathway was significantly upregulated in the cerebral cortex under the action of IDO-1 after DSS treatment, which ultimately induced the neurotoxic phenotype of astrocytes. To investigate whether gut microbiota is involved in IBD-induced Kyn pathway dysregulation, we performed intestinal flora 16S rRNA sequencing and found that DSS-induced colitis significantly altered the composition and diversity of the gut microbiota. Metabolic function analysis also showed that Tryptophan metabolism, NOD-like receptor signaling pathway and MAPK signaling pathway were significantly up-regulated in the 2% DSS group. A significant association between intestinal flora and Trp metabolism (both in serum and brain) was found by correlation analysis. Overall, this study revealed that DSS-induced colitis causes dysregulation of the Kyn pathway in serum and brain by affecting rate-limiting enzymes and intestinal flora.

Indexed as

ColitisGastrointestinal MicrobiomeInflammatory Bowel DiseasesAnimalsBrainIndoleamine-Pyrrole 2,3,-DioxygenaseKynurenineMiceMice, Inbred C57BLRNA, Ribosomal, 16STryptophanTryptophan OxygenaseIndoleamine-Pyrrole 2,3,-DioxygenaseKynurenineRNA, Ribosomal, 16STryptophanTryptophan OxygenaseDSS-induced colitisgut microbiotaindoleamine-2,3-dioxygenase (IDO)kynurenine pathway (KP)tryptophan metabolism

Identifiers

PMID36776388
PMCPMC9908955
OpenAlexW4318046607

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.